These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 30834619)

  • 1. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway.
    Wang Q; Shi M; Sun S; Zhou Q; Ding L; Jiang C; Bian T; Jia F; Liu Y; Qin J
    Biochem Biophys Res Commun; 2020 Apr; 524(3):656-662. PubMed ID: 32033754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
    Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
    BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
    Zhang A; Peng S; Sun S; Ye S; Zhao Y; Wu Q
    Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways.
    Fan H; Xin T; Dong X; Yang F; Zhang R; Feng S; He D; Guo H; Pang Q
    Exp Mol Pathol; 2021 Feb; 118():104571. PubMed ID: 33166495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
    Zheng Q; Diao S; Wang Q; Zhu C; Sun X; Yin B; Zhang X; Meng X; Wang B
    J Cell Mol Med; 2019 Jan; 23(1):357-369. PubMed ID: 30353649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.
    Wang J; Li X; Wu H; Wang H; Yao L; Deng Z; Zhou Y
    J Cell Biochem; 2019 Oct; 120(10):17142-17150. PubMed ID: 31111534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.
    Song W; Wang Z; Kan P; Ma Z; Wang Y; Wu Q; Yao X; Zhang B
    Biomed Res Int; 2018; 2018():6953506. PubMed ID: 30420967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.
    Yin H; Deng Z; Li X; Li Y; Yin W; Zhao G; Jiang D; Sun C; Zhou Y
    Cancer Genet; 2019 Sep; 237():1-9. PubMed ID: 31447061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway.
    Liu X; Wu X; Wang Y; Li Y; Chen X; Yang W; Jiang L
    Oncol Res; 2019 Mar; 27(4):415-422. PubMed ID: 29321087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.